- Home
- CUE vs CNF Comparison
CUE vs CNF Comparison
Compare CUE & CNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CUE | CNF |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.6M | 41.0M |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CUE | CNF |
|---|---|---|
| Price | $0.28 | $6.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 8.8K |
| Earning Date | 11-12-2025 | 08-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,100,000.00 | ★ $50,241,013.00 |
| Revenue This Year | N/A | $252.34 |
| Revenue Next Year | $25.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.23 | $2.36 |
| 52 Week High | $1.75 | $13.90 |
Technical Indicators
Market Signals| Indicator | CUE | CNF |
|---|---|---|
| Relative Strength Index (RSI) | 28.27 | 66.07 |
| Support Level | $0.23 | $6.10 |
| Resistance Level | $0.33 | $6.20 |
| Average True Range (ATR) | 0.05 | 0.19 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 16.34 | 94.94 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.